Gossamer Bio, Inc. (GOSS) vs Hyperion DeFi, Inc. (HYPD)
Gossamer Bio, Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. Gossamer Bio, Inc. and Hyperion DeFi, Inc. are of similar size ($66.8M and $64.8M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against 32.4%. Gossamer Bio, Inc. has the higher net margin (−235.0% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 16 metrics below, Gossamer Bio, Inc. leads on 8 and Hyperion DeFi, Inc. on 8.
Valuation
Profitability
| Metric | GOSS | HYPD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 78.35% | 65.16% |
| Operating margin | (311.70%) | 314.32% | 0.00% |
| Net margin | (235.00%) | (1,224.53%) | 0.00% |
| Free cash flow margin | (305.19%) | (5,509.35%) | 0.00% |
| Return on equity | 178.72% | (24.63%) | (57.72%) |
| Return on assets | (78.81%) | (20.32%) | (49.22%) |
| Return on invested capital | 0.00% | 2.73% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack